On August 16, 2018, the central government carried out the strongest accountability for the Changchun Changsheng company's problematic vaccine case: Bi Jingquan, Jin Yuhui, Li Jinxiu, Liu Changlong, Jiang Zhiying, Jiao Hong and other six provincial and ministerial officials were respectively resigned, dismissed, and ordered to take the blame.Resignation, in-depth inspection, etc.Wu Zhen, the former deputy director of the China Food and Drug Administration, was announced to be investigated.

The Central Commission for Discipline Inspection announced at 8 pm on August 16 that Wu Zhen, former member of the party group and deputy director of the State Food and Drug Administration, was suspected of serious violations of discipline and law, and is currently undergoing disciplinary review and supervision investigation by the Central Commission for Discipline Inspection and the State Supervisory Committee.

So far, Wu Zhen is the first provincial and ministerial official to be investigated for the Changchun Changsheng vaccine case.

According to the resume released by the Central Commission for Discipline Inspection, Wu Zhen was born in May 1958 in Nanfeng, Jiangxi Province, with a postgraduate degree.He is an old man in the drug supervision system. After he joined the work, he joined the Medical Education Science and Technology Department of the Jiangxi Provincial Department of Health as a cadre.After that, he entered the Pharmaceutical Administration Bureau of the Jiangxi Provincial Department of Health and successively served as the deputy director and then the director.In 1998 and 2003, after the two adjustments of the drug administration department in institutional reforms, Wu Zhen successively served as the director and secretary of the party group of the Jiangxi Provincial Food and Drug Administration, and the director and secretary of the party group of the Jiangxi Provincial Drug Administration.

In 2006, Wu Zhen left Jiangxi to work in Beijing, where he served as the deputy director of the State Food and Drug Administration and a member of the party group, and concurrently served as the secretary-general of the State Pharmacopoeia Commission the following year.Since 2013, he has served as the deputy director of the State Food and Drug Administration, and since 2015 he has also served as the deputy director of the National Health and Family Planning Commission.

After the start of the current round of party and state institutional reforms in March this year, the Food and Drug Administration was integrated into the State Administration for Market Regulation. Wu Zhen, who was 60 years old at the time, did not hold a post in the State Administration for Market Regulation. According to media reports, he had retired.

After becoming the deputy director of the State Food and Drug Administration in 2006, Wu Zhen has been in charge of drug registration, supervision, and review for a long time, holding a lot of power.The vaccine industry is also under his control, and some media call him the vaccine czar.Since 2014, he has been involved in two real-name reporting whirlpools.

The first was in August 2014. Zhang Yi, chairman of Henan Yisheng Pharmaceutical Co., Ltd., posted a report letter on his personal microblog between him and Ma Wenfang, a representative of the National People's Congress, in his capacity as a representative of the Henan Provincial People's Congress, accusing Wu Zhen of dereliction of duty and covering up his subordinates..

The report letter stated: Zhang Yi repeatedly reported to Wu Zhen the problems of his subordinate Yin Hongzhang. In 2006, when Yin Hongzhang was the director of the Biological Products Division of the Drug Registration Department of the State Food and Drug Administration, Zhang's company had been approved by the evaluation center to enter clinical trials.In 2010, Yin Hongzhang was transferred to the deputy director of the Drug Evaluation Center and used his power to dominate the subsequent review of this drug, which made the innovative drug that should have entered clinical trials fail again.review.

Zhang alleged that Wu Zhen deliberately covered up Yin Hongzhang's behavior without investigating it.

Last year, Yin Hongzhang was sentenced to 10 years in prison for accepting bribes, along with his wife and son.The court found that from 2002 to 2014, Yin Hongzhang's family of three received a total of more than 3.56 million yuan in property from biopharmaceutical companies.

It is worth noting that several vaccine manufacturers have been involved in the Yin Hongzhang case.

The second report was in 2016. Du Taoxin, a reporter from the Democracy and Legal Times, reported Wu Zhen with his real name, alleging that during Wu Zhen’s charge of vaccines, the Shanxi vaccine case, Jiangsu Yanshen, Hebei Forer rabies vaccine case, the 2013 hepatitis B vaccine case,In 2016, major cases such as the Shandong vaccine case occurred frequently, and Wu Zhen was suspected of abusing his power, dereliction of duty, and dereliction of duty.

Du Taoxin stated in the report letter that in March 2009, the National Institute of Pharmaceutical and Biological Products under the China Food and Drug Administration found that there were problems with the rabies vaccines produced by Jiangsu Yanshen and Hebei Forer.To take recall measures, but also concealed until December 2009.During the period of concealment, Wu Zhen personally intervened in Jiangsu Yanshen platform and gave him an order of influenza A vaccine with a total value of over 100 million yuan.

During the real-name reporting turmoil, on March 23, 2016, Wu Zhen responded to the issue of vaccine supervision at the sub-forum on the reform of the drug review and approval system of the Boao Forum for Asia.

Before the opening of this forum, the illegal vaccine case broke out in Shandong.In the sub-forum, in front of many media reporters, Wu Zhen said, I know everyone is running after me.He said at the time that Shandong vaccines do have loopholes in the circulation process, and vaccines are preventive products that should not cause physical harm to healthy people who are injected.The Food and Drug Administration, the Ministry of Public Security, and the National Health and Family Planning Commission are closely cooperating and will definitely handle the Shandong vaccine incident well.

A reporter asked, do you think vaccines are safe?Wu Zhen replied: If this question can be answered by me saying YES OR NO, then the forum can end immediately.After the sub-forum ended, many reporters flocked to the stage to continue asking questions, but Wu Zhen did not answer most of the questions directly.

When Wu Zhen came to Beijing from Jiangxi Province in September 2006 to serve as the deputy director of the State Food and Drug Administration, Zheng Xiaoyu was then the director of the State Food and Drug Administration.Three months later, Zheng Xiaoyu was sentenced to shuanggui and executed in May 2007.

Wu Zhen's name appeared in Zheng Xiaoyu's verdict as a witness.

According to Zheng Xiaoyu's judgment, in 2000, Zheng Xiaoyu requested support for a Guangdong company's application for cross-provincial pharmaceutical retail chain operations.In 2003, when Zheng Xiaoyu inspected the company, the person in charge of the company asked Zheng Xiaoyu for help in handling the drug business license.Zheng Xiaoyu instructed Wu Zhen, then director of the Jiangxi Provincial Food and Drug Administration, to write a letter to the State Food and Drug Administration for instructions, and the State Food and Drug Administration will approve and resolve the matter.

In other words, in the case of Zheng Xiaoyu, Wu Zhen once testified that Zheng Xiaoyu accepted a request from a company in Guangdong to help him with affairs.

After Zheng Xiaoyu was sacked, Wu Zhen has publicly stated his position several times, thinking that the entire drug supervision system cannot be denied because of the problems of Zheng Xiaoyu and a few people.

In February 2007, when he was a guest on the Chinese government website and communicated with netizens, Wu Zhen said: I want to say here that although there have been corruption cases like Zheng Xiaoyu and Cao Wenzhuang in our drug supervision system, it cannot be because of their problems.Denying the team of drug supervision cannot deny the work and achievements of the drug supervision system over the years, nor can it shake our confidence in doing a good job in supervision and checking for the people.

In December 2007, at the press conference of the State Council Information Office, Wu Zhen said that Zheng Xiaoyu had been severely punished by the law, and the news had already reported the results, and I think everyone already knew.Zheng Xiaoyu's corruption case has had some negative impacts on the drug supervision system and shamed us drug supervisors. We are saddened by this.

Wu Zhen also said at the time: You can’t deny a system or this team because of one person’s problem. I can tell you with confidence that the team in China’s food and drug supervision is good, and this team can afford it.It is a team with combat effectiveness that dares to face hardships.